Industry and Business Archives - Oncology Central Oncology Central

i
i

25 Apr 2019 Opinion
Enhancing and improving CAR-T cell therapy: an interview with Bruce Levine
25 Apr 2019 News
One in 10 cancer patients denied drugs recommended by their doctor, study finds
24 Apr 2019 Renal
Keytruda® in combination with Inlyta® receives US FDA approval for renal cell carcinoma
16 Apr 2019 News
Oncology conferences and event highlights: April–June 2019
16 Apr 2019 Lung
US FDA expands the approval of Keytruda® in Stage III NSCLC
10 Apr 2019 Lung
KEYNOTE trials demonstrate improved survival with pembrolizumab in elderly patients
5 Apr 2019 Opinion
Direct drug delivery and electroporation for internal tumors: a new platform developed by OncoSec
28 Mar 2019 Lung
Imfinzi made available on the NHS for Stage III NSCLC patients
19 Mar 2019 Lung
US FDA approves the first immunotherapy for extensive-stage small-cell lung cancer
13 Mar 2019 Industry and business
AACR calls on Congress to reject Trump’s NIH budget proposal
11 Mar 2019 Breast
Tecentriq® gains accelerated US FDA approval for PD-L1-positive, triple-negative breast cancer
8 Mar 2019 Cancer biology and pathology
Scientific survival suggestions: V. Craig Jordan’s top 10 tips